Parasite | Eso | Sto | Cancer | ESD
[´Ù¾çÇÑ ´ëÀå Áúȯ 028 - Endometrial cancer + colon cancer]
2016³â 4¿ù 28ÀÏ ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ¿¡¼ ovary cancer ¼ö¼ú ÈÄ CT »ó rectosigmoid junction ºÎÀ§°¡ µÎ²¨¿ö ½ÃÇàÇÑ ´ëÀå³»½Ã°æ Á¶Á÷°Ë»ç¿¡¼ metastatic serous carcinoma°¡ ³ª¿Â °æ¿ì¸¦ ¼Ò°³ÇÏ¿´½À´Ï´Ù.
±×·¯³ª »êºÎÀΰú ȯÀÚ¿¡¼ ´ëÀå º´¼Ò°¡ º¸ÀÎ´Ù°í ¸ðµÎ »êºÎÀΰú ÁúȯÀÇ ´ëÀå ħÀ± ȤÀº ´ëÀå ÀüÀÌ´Â ¾Æ´Õ´Ï´Ù. Double primary cancer°¡ ¾ó¸¶µçÁö °¡´ÉÇϱ⠶§¹®ÀÔ´Ï´Ù. ¾Æ·¡ »çÁøÀ» º¸½Ê½Ã¿À.
Uterus, total hysterectomy with pelvic lymph node dissection:
Endometrioid adenocarcinoma, not otherwise specified, grade I
1) invasion depth: confined to endometrium
2) tumor size: 2.5x1.7cm
3) lymphovascular invasion without D2-40 immunohistochemistry : negative
4) no metastasis in all 13 regional lymph nodes (pN0)
Descending colon, left hemicolectomy:
Adenocarcinoma, poorly differentiated (grade 3, solid pattern)
1. Location: descending colon
2. Gross type: ulceroinfiltrative
3. Size: 5.9x3.5 cm
4. Depth of invasion: invades pericolic adipose tissue(pT3)
5. Resection margin: free from carcinoma
6. Regional lymph node metastasis : No metastasis in all 23 regional lymph nodes(pN0)
7. Lymphatic invasion: not identified
8. Venous invasion: not identified
9. Perineural invasion: not identified
10. Tumor budding : positive (5-9)
11. Micropapillary component: no
12. Tumor border: infiltrative
13. Peritoneal cytology: negative
14. Pathologic staging: pT3 N0
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.